advertisement
Antioxidants (Basel, Switzerland) 32
Showing records 1 to 25 | Display all abstracts in Antioxidants (Basel, Switzerland)108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Naguib S
Antioxidants (Basel, Switzerland) 2023; 12:
107883 m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases
Ni Y
Antioxidants (Basel, Switzerland) 2023; 12:
107884 Mitochondrial Open Reading Frame of the 12S rRNA Type-c: Potential Therapeutic Candidate in Retinal Diseases
Mohtashami Z
Antioxidants (Basel, Switzerland) 2023; 12:
107882 Profiling the miRNA from Exosomes of Non-Pigmented Ciliary Epithelium-Derived Identifies Key Gene Targets Relevant to Primary Open-Angle Glaucoma
Pattabiraman PP
Antioxidants (Basel, Switzerland) 2023; 12:
107881 TRAP1 Is Expressed in Human Retinal Pigment Epithelial Cells and Is Required to Maintain their Energetic Status
Ramos Rego I
Antioxidants (Basel, Switzerland) 2023; 12:
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
DeJulius CR
Antioxidants (Basel, Switzerland) 2023; 12:
107882 Profiling the miRNA from Exosomes of Non-Pigmented Ciliary Epithelium-Derived Identifies Key Gene Targets Relevant to Primary Open-Angle Glaucoma
Feinstein V
Antioxidants (Basel, Switzerland) 2023; 12:
107881 TRAP1 Is Expressed in Human Retinal Pigment Epithelial Cells and Is Required to Maintain their Energetic Status
Silvério D
Antioxidants (Basel, Switzerland) 2023; 12:
107884 Mitochondrial Open Reading Frame of the 12S rRNA Type-c: Potential Therapeutic Candidate in Retinal Diseases
Singh MK
Antioxidants (Basel, Switzerland) 2023; 12:
107883 m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases
Zhang H
Antioxidants (Basel, Switzerland) 2023; 12:
107884 Mitochondrial Open Reading Frame of the 12S rRNA Type-c: Potential Therapeutic Candidate in Retinal Diseases
Neto FT
Antioxidants (Basel, Switzerland) 2023; 12:
107882 Profiling the miRNA from Exosomes of Non-Pigmented Ciliary Epithelium-Derived Identifies Key Gene Targets Relevant to Primary Open-Angle Glaucoma
Beit-Yannai E
Antioxidants (Basel, Switzerland) 2023; 12:
107883 m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases
Chu L
Antioxidants (Basel, Switzerland) 2023; 12:
107881 TRAP1 Is Expressed in Human Retinal Pigment Epithelial Cells and Is Required to Maintain their Energetic Status
Eufrásio MI
Antioxidants (Basel, Switzerland) 2023; 12:
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Backstrom JR
Antioxidants (Basel, Switzerland) 2023; 12:
107881 TRAP1 Is Expressed in Human Retinal Pigment Epithelial Cells and Is Required to Maintain their Energetic Status
Pinhanços SS
Antioxidants (Basel, Switzerland) 2023; 12:
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Haider AA
Antioxidants (Basel, Switzerland) 2023; 12:
107883 m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases
Zhao Y
Antioxidants (Basel, Switzerland) 2023; 12:
107884 Mitochondrial Open Reading Frame of the 12S rRNA Type-c: Potential Therapeutic Candidate in Retinal Diseases
Salimiaghdam N
Antioxidants (Basel, Switzerland) 2023; 12:
107881 TRAP1 Is Expressed in Human Retinal Pigment Epithelial Cells and Is Required to Maintain their Energetic Status
Lopes da Costa B
Antioxidants (Basel, Switzerland) 2023; 12:
107884 Mitochondrial Open Reading Frame of the 12S rRNA Type-c: Potential Therapeutic Candidate in Retinal Diseases
Hasanpour H
Antioxidants (Basel, Switzerland) 2023; 12:
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Ang JM
Antioxidants (Basel, Switzerland) 2023; 12:
107881 TRAP1 Is Expressed in Human Retinal Pigment Epithelial Cells and Is Required to Maintain their Energetic Status
Lopes da Costa B
Antioxidants (Basel, Switzerland) 2023; 12:
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Boal AM
Antioxidants (Basel, Switzerland) 2023; 12:
107884 Mitochondrial Open Reading Frame of the 12S rRNA Type-c: Potential Therapeutic Candidate in Retinal Diseases
Kenney MC
Antioxidants (Basel, Switzerland) 2023; 12:
